JenniferM.PuckMD
Allergy & Immunology • San Francisco, CAProfessor, Pediatrics, UCSF School of Medicine
Dr. Puck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 Fouth Street, 4th Floor
San Francisco, CA 94158Phone+1 415-476-2188
Education & Training
Baylor College of Medicine (Houston)Residency, Pediatrics, 1978 - 1981
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1977 - 1978- Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1975 - 1976
Harvard Medical SchoolClass of 1975
Certifications & Licensure
CA State Medical License 2006 - 2025
MD State Medical License 1994 - 2007
PA State Medical License 1984 - 1994
TX State Medical License 1979 - 1985- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1992
Publications & Presentations
PubMed
- 10 citationsGenomic Analysis of Historical Cases with Positive Newborn Screens for Short-Chain Acyl-CoA Dehydrogenase Deficiency Shows That a Validated Second-Tier Biochemical Tes...Aashish N. Adhikari, Robert J. Currier, Hao Tang, Coleman T. Turgeon, Robert L. Nussbaum
International Journal of Neonatal Screening. 2020-05-26 - 95 citationsSomatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndromeKennichi C. Dowdell, Julie E. Niemela, Susan Price, Joie Davis, Ronald L. Hornung
Blood. 2010-06-24 - 67 citationsAn essential role for the Zn2+ transporter ZIP7 in B cell developmentConsuelo Anzilotti, David J. Swan, Bertrand Boisson, Mukta Deobagkar-Lele, Catarina Oliveira
Nature Immunology. 2019-02-04
Abstracts/Posters
- Enhanced Transduction Lentivector Gene Therapy for Treatment of Older Patients with X-Linked Severe Combined ImmunodeficiencyJennifer Puck, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Lentiviral Gene Therapy with Low Dose Busulfan for Infants with X-SCID Results in the Development of a Functional Normal Immune System: Interim Results of an Ongoing P...Jennifer Puck, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Gene Therapy for ART-SCID Shows “Amazing” Results in 10 ChildrenDecember 29th, 2022
- Gene Therapy Could Save Children from a Rare Genetic DiseaseDecember 22nd, 2022
Should We Sequence Newborns’ DNA? The Answer Is Complicated, Study FindsAugust 11th, 2020- Join now to see all
Grant Support
- Inherited Disorders Of Lymphocyte DevelopmentNational Institute Of Allergy And Infectious Diseases2010–2012
- Pilot Programpilot/Demonstration Project Program (PPP)National Institute Of Allergy And Infectious Diseases2011
- Newborn Screening For SCID In A High-Risk PopulationEunice Kennedy Shriver National Institute Of Child Health &Human Development2008–2009
- Clinical And Basic Studies In Severe Combined ImmunodefiNational Human Genome Research Institute2004–2005
- Genetic Analysis Of Host Defense DisordersNational Human Genome Research Institute1997–2005
- Gene Transfer For Therapy Of Immunodeficiency DiseaseNational Human Genome Research Institute2003
- IL 2 Receptor Gamma Chain Mutations In SCIDNational Human Genome Research Institute2001–2003
- Mutations Of Programmed Cell Death Gene FASNational Human Genome Research Institute1995–2003
- IL 2 Receptor Gamma Chain Mutations In Severe CombinedimNational Human Genome Research Institute2002
- Gene Transfer For Therapy Of IL 2 Receptor Gamma ChaindeNational Human Genome Research Institute2002
- Gene Transfer Therapy Of IL 2 Receptor G Chain ScidiNational Human Genome Research Institute2001
- IL 2 Receptor Gamma Chain Mutations In Severe CombinedimmunodeficiencyNational Human Genome Research Institute2000
- Gene Transfer For Therapy Of IL 2 Receptor Gamma Chaindeficient X Linked ScidiNational Human Genome Research Institute2000
- IL 2 Receptor Gamma Chain Mutations In Severe Combined ImmunodeficiencyNational Human Genome Research Institute1996–1999
- Gene Transfer For Therapy Of IL 2 Receptor Gamma Chain Deficient X Linked SCIDNational Human Genome Research Institute1995–1999
- IL 2 Receptor Chain Mutations In X Linked Severe Combine ImmunodeficiencyNational Human Genome Research Institute1995
- Xcen-Xq21.3 In Overlapping Yeast Artificial ChromosomesNational Human Genome Research Institute1991–1992
- Genetic Analysis Of Immunodeficiency DiseasesEunice Kennedy Shriver National Institute Of Child Health &Human Development1988–1992
- Gene Expression During Immunoregulatory Cell DevelopmentEunice Kennedy Shriver National Institute Of Child Health &Human Development1985–1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
